Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Cancer Genomics & Proteomics
  • Other Publications
    • Cancer Genomics & Proteomics
    • Anticancer Research
    • In Vivo
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Cancer Genomics & Proteomics

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin
Research ArticleArticles
Open Access

Contribution of MRE11, RAD50, and NBS1 Genotypes to Bladder Cancer Susceptibility

CHENG-HSI LIAO, WEN-SHIN CHANG, HOU-YU SHIH, YUN-CHI WANG, CHE-LUN HSU, SHU-YU CHANG, CHAO-HSIANG CHANG, WEN-CHI CHEN, DA-TIAN BAU and CHIA-WEN TSAI
Cancer Genomics & Proteomics July 2025, 22 (4) 575-591; DOI: https://doi.org/10.21873/cgp.20523
CHENG-HSI LIAO
1Taichung Armed Forces General Hospital, Taichung, Taiwan, R.O.C.;
2National Defense Medical Center, Taipei, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WEN-SHIN CHANG
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
4Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HOU-YU SHIH
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
4Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
YUN-CHI WANG
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
4Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHE-LUN HSU
4Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SHU-YU CHANG
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
4Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CHAO-HSIANG CHANG
5School of Medicine, China Medical University, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
WEN-CHI CHEN
5School of Medicine, China Medical University, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DA-TIAN BAU
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
4Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
6Department of Bioinformatics and Medical Engineering, Asia University, Taichung, Taiwan, R.O.C.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: 013280{at}tool.caaumed.org.tw 017891{at}tool.caaumed.org.tw
CHIA-WEN TSAI
3Terry Fox Cancer Research Laboratory, Department of Medical Research, China Medical University Hospital, Taichung, Taiwan, R.O.C.;
4Graduate Institute of Biomedical Sciences, China Medical University, Taichung, Taiwan, R.O.C.;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: 013280{at}tool.caaumed.org.tw 017891{at}tool.caaumed.org.tw
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Physical maps of the MRN polymorphic sites in (A) MRE11, (B) RAD50, and (C) NBS1.

Tables

  • Figures
  • Table I.
  • Table II.
  • Table III.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Table III.
    • Download figure
    • Open in new tab
    • Download powerpoint
  • Table IV.
  • Table V.
PreviousNext
Back to top

In this issue

Cancer Genomics - Proteomics: 22 (4)
Cancer Genomics & Proteomics
Vol. 22, Issue 4
July-August 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Cancer Genomics & Proteomics.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Contribution of MRE11, RAD50, and NBS1 Genotypes to Bladder Cancer Susceptibility
(Your Name) has sent you a message from Cancer Genomics & Proteomics
(Your Name) thought you would like to see the Cancer Genomics & Proteomics web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
3 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Contribution of MRE11, RAD50, and NBS1 Genotypes to Bladder Cancer Susceptibility
CHENG-HSI LIAO, WEN-SHIN CHANG, HOU-YU SHIH, YUN-CHI WANG, CHE-LUN HSU, SHU-YU CHANG, CHAO-HSIANG CHANG, WEN-CHI CHEN, DA-TIAN BAU, CHIA-WEN TSAI
Cancer Genomics & Proteomics Jul 2025, 22 (4) 575-591; DOI: 10.21873/cgp.20523

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Contribution of MRE11, RAD50, and NBS1 Genotypes to Bladder Cancer Susceptibility
CHENG-HSI LIAO, WEN-SHIN CHANG, HOU-YU SHIH, YUN-CHI WANG, CHE-LUN HSU, SHU-YU CHANG, CHAO-HSIANG CHANG, WEN-CHI CHEN, DA-TIAN BAU, CHIA-WEN TSAI
Cancer Genomics & Proteomics Jul 2025, 22 (4) 575-591; DOI: 10.21873/cgp.20523
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

  • Association of Matrix Metalloproteinase-11 Genotypes With Taiwan Gastric Cancer Risk and Clinical Features
  • Exploring the Genetic Role of Matrix Metalloproteinase-13 Variants in Pterygium Risk
  • Contribution of Xeroderma Pigmentosum Complementation Group C Genotypes to Colorectal Cancer in Taiwanese
  • Impact of Cyclin-dependent Kinase Inhibitor 1A Genotypes on Prostate Cancer Susceptibility Prediction
  • Google Scholar

More in this TOC Section

  • Prognostic Significance of EZH2-Related Gene Variants in Patients With Prostate Cancer Undergoing Androgen Deprivation Therapy
  • Elevated Stanniocalcin-1 Expression in Uveal Melanoma Predicts Poor Patient Prognosis
  • C1orf50 Drives Malignant Melanoma Progression Through the Regulation of Stemness
Show more Articles

Keywords

  • Bladder cancer
  • Genotype
  • double strand breaks
  • polymorphism
  • Taiwan
Cancer & Genome Proteomics

© 2026 Cancer Genomics & Proteomics

Powered by HighWire